HOME >> BIOLOGY >> NEWS
Amgen introduces new rheumatoid arthritis book and first online resource for access to interleukin-1 (IL-1) research

THOUSAND OAKS, Calif., October 30, 2000 -- Amgen (NASDAQ:AMGN) today announced the introduction of Interleukin-1.com and Proinflammatory and Anti-Inflammatory Cytokines in Rheumatoid Arthritis: A Primer for Clinicians, two new resources designed to provide health care professionals with updated, reliable and comprehensive information about the role of cytokines, specifically interleukin-1 (IL-1), in rheumatoid arthritis (RA).

Interleukin-1.com is the first Web site with the latest scientifically rigorous clinical data regarding IL-1 in RA. As 65 percent of physicians -- more than twice as many as four years ago -- use the Internet to access medical research today , the Web site provides a quick and easy way for rheumatologists to keep informed about new research through a medium many already utilize.

"There is mounting evidence that IL-1 plays a fundamental role in the disease progression of rheumatoid arthritis," said Keith Leonard, vice president of rheumatology marketing at Amgen. "As the only online resource about IL-1, Interleukin-1.com meets a need for rheumatologists and other health care professionals who want access to the latest research. It is another example of Amgen's commitment to research and scientific exchange in the area of rheumatology."

The Web site consists of access to published materials, including relevant articles and abstracts, plus the new expanded version of the popular Proinflammatory and Anti-Inflammatory Cytokines in Rheumatoid Arthritis: A Primer for Clinicians. This book, authored by Dr. Charles A. Dinarello, professor of medicine at the University of Colorado School of Medicine, is intended to familiarize general health care professionals, as well as rheumatologists, with aspects of cytokine biology as they relate to the understanding of rheumatoid arthritis in humans.

The field of cytokine biology is rapidly expanding and the primer offers insight into the groundbreaking clinical work le
'"/>

Contact: Rebecca Hamm, Amgen
rhamm@amgen.com
805-447-3872
Porter Novelli
28-Oct-2000


Page: 1 2

Related biology news :

1. DuPont introduces in-home personal protection from dangers of hurricanes
2. New textbook introduces students to the foundations, applications of nanotechnology
3. New paper in Science introduces revolutionary new paradigm for fishery management
4. Regeneration Technologies introduces advancements at AAOS
5. Applied Biosystems introduces new chemistries to increase DNA sequencing productivity
6. Applied Biosystems introduces new system for protein and metabolite analysis
7. The impact of genetic variations on the treatment of early rheumatoid arthritis
8. Scientists discover genetic marker responsible for two-fold increase in risk of rheumatoid arthritis
9. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
10. Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
11. Gene therapy promising for rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to ... a near term focus on Type 2 diabetes and associated comorbidities. , Justin ... therapeutic areas and classes. As Chief Commercial Officer, Justin will lead Better ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming ... Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. ... what is the most effective way to complete one? Will the study comply ...
(Date:7/2/2020)... ... July 02, 2020 , ... Dutch ... the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 ... The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader in ... “BUILDING FOR LIFE.” The adoption of this taglines comes at a time of ... capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... 200 of the top radiation centers in 16 countries, has reached its 20th ... SDX® is now in routine use at top universities including University of Pennsylvania, ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... the early detection and prevention of high-burden diseases, and Centric Consulting, a business ... healthcare organizations to utilize existing data in order to identify and prioritize patients ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., ... hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of ...
Breaking Biology Technology:
Cached News: